Clinical trial
Intermittent HEMOdialysis Anticoagulation With TINzaparin Versus Unfractionated Heparin: A Pilot Multicentre Randomized Controlled Trial (HEMO-TIN Trial)
NCT01930396 is registered in ClinicalTrials.gov with Christine Ribic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent HEMOdialysis Anticoagulation With TINzaparin Versus Unfractionated Heparin: A Pilot Multicentre Randomized Controlled Trial (HEMO-TIN Trial)
- Lead sponsor
- Christine Ribic
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- September 30, 2016
- Enrollment
- 191 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.